Sudeep Pharma IPO Subscription Hits 5.09x on Day 3: GMP & Review Explained

Sudeep Pharma’s IPO gained strong attention as the issue hit a subscription level of 5.09x on 24 November 2025, the third day of bidding. This fast rise shows clear interest from retail and institutional investors. Many traders were watching this IPO because the company works in a steady and essential sector. Sudeep Pharma makes key ingredients that help medicines stay stable, safe, and effective. That makes the business important for global drug makers.